University of Oxford Does it Again! Now Showing that AstraZeneca’s Pulmicort Reduces COVID-19 Hospitalization Rate by 90%

University of Oxford Does it Again! Now Showing that AstraZeneca’s Pulmicort Reduces COVID-19 Hospitalization Rate by 90%

University of Oxford emerges during this pandemic has perhaps the most influential investigational unit worldwide. The recent University of Oxford led STOIC study results reveal that inhaled budesonide, a common asthma treatment, reduces the need for hospitalization for patients tested positive for COVID-19. This 28-day study involved 148 patients: half of them took 800 micrograms of the study drug with trade name Pulmicort (AstraZeneca) twice a day. The study outcomes are promising with the inhaled budesonide actually lowering the probability of urgent care or hospitalization by 90% during the study period. University of Oxford does it again, contributing to the world yet another key piece of medicinal evidence thanks to their ongoing research programs. In the RECOVERY trial, Oxford showed the world that another corticosteroid, dexamethasone, could reduce the COVID-19 death rate for severe to critically ill COVID-19 patients receiving mechanical ventilation versus the standard of care. The prestigious British institution also recently announced the planning of the PRINCIPLE trial as well—the study of ivermectin as yet another promising economical generic to treat COVID-19, at lea...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee